Marketing research of pharmaceutical market for the treatment of hepatobiliary system with a perspective design of plantbased medicinal product
DOI:
https://doi.org/10.24959/uekj.16.37Keywords:
liver and gallbladder diseases, marketing analysis, pharmaceutical market, syrupsAbstract
In recent years, worldwide there is a clear tendency of increasing the number of hepatobiliary diseases (DHBS). According to the data of research of the local pharmaceutical market for the treatment of liver and gallbladder diseases it was revealed that Ukrainian producers represent 34 % of the analyzed medicines. The most group represented consists of mono- and combined phytopreparations – 47 %. Among the plants that exhibit hepatoprotective, choleretic activity, the most common are artichoke (Cynara), Silybum marianum, Helichrysum arenarium. The ranking of the foreign countries which supply medicinesof analyzed group to Ukrainian pharmaceutical market has revealed that the leaders in regards with medicines represented are the following: India (15 %), Germany (13 %) and Russian Federation (8 %). Among pharmaceutical forms the most represented are capsules (28 %), tablets (25%) and injection
solutions (13 %). Such dosage form as a syrup is represented by the only drug that indicates the relevance of developing original medicine with combined effect.
References
Державний реєстр лікарських засобів України [Електронний ресурс] / МОЗ України. – К., 2015. – Режим доступу : http: // www.drlz.kiev.ua.
Державний формуляр лікарських засобів / ред. кол.: М. Л. Аряєв, В. Г. Бебешко, Т. А. Бухтіарова та ін. – К., 2015. – Вип. 7. – 845 с.
Звягинцева Т. Д. Хронические диффузные заболевания печени: патогенетические подходы к лечению / Т. Д. Звягинцева, С. В. Глущенко // Здоров’я України. – 2010. – № 1. – С. 46-47.
Компендиум 2015 – лекарственные препараты / под ред. В. Н. Коваленко. – К.: Морион, 2015. – 1408 с.
Ивашкин В. Т. Болезни печени и желчевыводящих путей: руководство для врачей / В. Т. Ивашкин. – М.: ИД «М-Вести», 2005. – 536 с.
Ильченко А. А. Заболевания желчного пузыря и желчных путей / А. А. Ильченко. – М.: Анахарсис, 2006. – 448 с.
The Burden of liver disease in Europe. A review of available epidemiological data / M. Blachier, H. Leleu, M. Peck-Rado-savljevic et al. // J. Hepatol. – 2013. – Mar; 58(3). – Р. 593-608.
Trends in mortality from chronic liver disease / U. Fedeli, F. Avossa, S. Guzzinati et al. // J. Ann. Epidemiol. – 2014. – Jul; 24(7). – Р. 522-526.
The global burden of liver disease: the major impact of China / F. S. Wang, J. G. Fan, Z. Zhang et al. // Hepatol. – 2014. – Dec; 60(6) – Р. 2099-2108.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
